CIK 0001618835
- Non-accelerated filer
- Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208527075
- Phone
- +1 858-550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-02-04 | Locke Kenneth W Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2015-12-17 | Locke Kenneth W Chief Scientific Officer | Sale | −598 | $1.26 | $753 | 0 |
| 2015-11-18 | Locke Kenneth W Chief Scientific Officer | Option exercise | +6,098 | $8.30 | $51K | 6,391 |
| 2015-11-18 | Locke Kenneth W Chief Scientific Officer | Sale | −6,098 | $8.30 | $51K | 293 |
| 2015-11-18 | Locke Kenneth W Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,093 | 23,191 | ||
| 2015-11-18 | Locke Kenneth W Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,005 | 11,366 | ||
| 2015-02-10 | Locke Kenneth W Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +16,288 | 16,288 |
Page 1 of 1 · 7 trades